Osteoporosis
📧 Sign up to get email alerts when something new happens for Osteoporosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Improved Screening for Osteoporosis
A completed clinical trial reports improvements in screening for osteoporosis.
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
This clinical trial update describes routine validation and reproducibility testing of laboratory assays and techniques used in endocrine, c…
-
FDA approval · 2025-10-29FDA Approved: WYOST — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for WYOST (denosumab) submitted by Sandoz Inc, expanding the product's indications.
-
FDA approval · 2025-10-29FDA Approved: STOBOCLO — Original Application (CELLTRION USA, Inc.)
FDA approved STOBOCLO (denosumab-BMWO) from Celltrion USA as an original application; a denosumab biosimilar with indications including oste…
-
CLINICAL_TRIALS trial_result · 2025-10-29Clinical Trial Update: Effect of Soluble Corn Fiber Supplementation for 1 Year on Bone Metabolism in Adolescents [Phase 2]
Phase 2 trial evaluated one year of soluble corn fiber supplementation on bone metabolism in adolescents with osteoporosis; results have bee…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-29Clinical Trial Update: Denosumab to Prevent High-Turnover Bone Loss After Bariatric Surgery [Phase 4]
Phase 4 trial evaluated denosumab to prevent high-turnover bone loss after bariatric surgery; results have been posted.
-
CLINICAL_TRIALS research · 2025-10-28Clinical Trial Update: Utility of Cortical Bone Tissue Properties in the Assessment of Fracture Risk [NA]
This clinical trial update addresses the potential of cortical bone tissue properties to improve fracture risk assessment in patients with d…
-
EMA approval · 2025-10-22EMA Authorised: Prolia (denosumab) — Amgen Europe B.V.
The EMA authorised Prolia (denosumab) from Amgen Europe B.V. for osteoporosis, including postmenopausal osteoporosis. The decision date was …
-
FDA approval · 2025-10-16FDA Approved: YORVIPATH — Supplemental Application (Ascendis Pharma, Endocrinology, Inc.)
The FDA approved a supplemental application for YORVIPATH (palopegteriparatide) from Ascendis Pharma Endocrinology, Inc. The approval indica…
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: Models of Primary Osteoporosis Screening in Male Veterans [NA]
This clinical trial evaluated models for screening primary osteoporosis in male veterans, with results posted after the study's completion.
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty [NA]
This clinical trial update describes a Johns Hopkins University–sponsored study testing a surgeon-initiated bone health referral pathway for…
-
EMA approval · 2025-10-10EMA Authorised: Teriparatide Sun (teriparatide) — Sun Pharmaceutical Industries Europe B.V.
The EMA authorised Teriparatide Sun for osteoporosis, including postmenopausal osteoporosis.
-
EMA approval · 2025-10-09EMA Authorised: Zadenvi (denosumab) — Zentiva k.s.
EMA authorised Zadenvi (denosumab) for osteoporosis, including postmenopausal osteoporosis, with Zentiva k.s. as the marketing authorisation…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis 2 (ZOLARMAB2) [Phase 4]
Phase 4 trial examining zoledronate after denosumab in postmenopausal osteoporosis; the study (ZOLARMAB2) is currently active but not recrui…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: CFTR Modulator Effects on Bone and Muscle in Adults With Cystic Fibrosis
This clinical trial update reports on studying the effects of CFTR modulator therapy on bone density and muscle in adults with cystic fibros…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Lutein, Zeaxathin, and Fish Oil Supplementation [NA]
This Clinical Trial Update notes a Texas A&M University-sponsored study evaluating lutein, zeaxanthin, and fish oil supplementation. The tri…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Profylactic Treatment for Patients in Risk Osteoporosis [NA]
A recruiting clinical trial evaluating a prophylactic treatment for individuals at risk of osteoporosis or with osteopenia.
-
EMA approval · 2025-09-26EMA Authorised: Ibandronic acid Accord (ibandronic acid) — Accord Healthcare S.L.U.
The EMA authorised Accord Healthcare S.L.U.'s ibandronic acid product under a marketing authorization. The approval covers indications relat…
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Bone Mineral Density (BMD) in HIV Infection [NA]
A terminated clinical trial at University Hospital Strasbourg investigated bone mineral density in HIV infection, focusing on osteopenia and…
-
FDA approval · 2025-09-26FDA Approved: CALCITONIN SALMON — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' original application for Calcitonin Salmon (generic), marking the entry of a generic calcitonin product…
-
EMA approval · 2025-09-25EMA Authorised: Zoledronic acid Teva (zoledronic acid) — Teva B.V.
The EMA authorised Teva B.V.'s Zoledronic acid product for bone-related conditions and cancer-related bone disease. The active substance is …
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: Romosozumab in Women With Chronic SCI [Phase 2]
A Phase 2 trial evaluating romosozumab for osteoporosis in women with chronic spinal cord injury has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis [NA]
This clinical trial update assesses the efficacy of a structured exercise and nutritional intervention for sarcopenia in patients with osteo…
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Effect of Aerobic Exercise Versus Resistance Exercise on Bone Density in Postmenopausal Diabetic Women [NA]
A completed trial comparing aerobic exercise to resistance exercise on bone density in postmenopausal women with diabetes, focusing on osteo…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Anticholinergic Burden and Osteoporosis in Rheumatoid Arthritis
A Balikesir University-sponsored clinical trial is evaluating the relationship between anticholinergic burden and osteoporosis/fracture risk…